This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication. The contract has a firm fixed price, a ceiling value of $11,964.61, and a period of performance ending on May 13, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication, with a ceiling value of $8,348.05 and a completion date of November 26, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a diabetes medication. The contract has a ceiling value of $5,771.64 and runs through December 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication, with a ceiling value of $4,642.12 and a period of performance through March 26, 2025. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for diabetes management. The contract has a ceiling value of $35,522.28 and a period of performance through April 1, 2025. The contract is a firm fixed price delivery order, and there is no set-aside designation....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,947.55 contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for diabetes management. The order has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for the treatment of diabetes. The contract has a firm fixed price of $35,254.15 and a period of performance through January 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for diabetes management. The contract has a ceiling value of $3,282.36 and a performance period ending on May 13, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty medication. The contract has a ceiling value of $37,999.38 and a period of performance through October 30, 2024. This delivery order is placed against AmerisourceBergen's larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication, with a ceiling value of $54,045.02 and a period of performance through March 19, 2025. The contract is a firm fixed-price, non-set-aside vehicle. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...